Tapemark has acquired the iontoPatch business from Travanti Pharma, Inc., a wholly owned subsidiary of Teikoku Pharma USA, Inc. The iontoPatch, product line along with a suite of iontophoretic technology for use in medical devices and cosmetics, will be marketed under the Travanti Medical name. Andy Rensink, Tapemark’s president, remarked, “Tapemark is excited to add the iontoPatch technology to our existing delivery platforms, SNAP and SoluStrip, both of which support custom manufacturin...